TheChek News Flow

>>> Up

* Alexandria Group Raised to Accumulate at Inderes; PT 10.50 euros

* Bunzl Raised to Buy at Deutsche Bank; PT 3,475 pence

* Capita Raised to Outperform at RBC; PT 20 pence

* Choice Hotels Raised to Neutral at Redburn; PT $132

* Deutsche Bank PT Raised to 26 euros from 22 euros at RBC

* EQT Raised to Buy at ABG; PT 400 kronor

* Swiss Re PT raised at Goldman Sachs from 143 to 150 CHF

* Thales Raised to Reduce at AlphaValue/Baader
* Vaisala Raised to Accumulate at Inderes; PT 53 euros

* Viridien Raised to Equal-Weight at Barclays; PT 100 euros

* Wyndham Hotels Raised to Buy at Redburn; PT $115

>>> Down

* Embraer ADRs Cut to Peerperform at Wolfe

* Maire Cut to Underweight at Barclays; PT 11 euros

* Munich Re Cut to Neutral at Goldman; PT 573 euros

* Novo Cut to Sell at Intron Health; PT 460 kroner

* SBM Offshore Cut to Equal-Weight at Barclays; PT 25 euros

* SKF Cut to Hold at SEB Equities; PT 245 kronor
* Thule Cut to Hold at SEB Equities; PT 345 kronor

* Travelers Cut to Hold at HSBC; PT $270

>>> Initiation

* Banca Mediolanum Rated New Overweight at JPMorgan

* Campbell's Reinstated Equal-Weight at Morgan Stanley; PT $40

* Conagra Rated New Equal-Weight at Morgan Stanley; PT $27

* General Mills Rated New Underweight at Morgan Stanley; PT $53

* Hannover Re Reinstated Buy at Goldman; PT 312 euros

* Hershey Rated New Equal-Weight at Morgan Stanley; PT $183

* HBX Group International Rated New Overweight at Morgan Stanley

* HBX Group International Rated New Overweight at Barclays

* HBX Group International Rated New Buy at Citi; PT 14 euros

* HBX Group International Rated New Outperform at Oddo BHF
* John Mattson Rated New Hold at SEB Equities; PT 63 kronor

* Kraft Heinz Reinstated Underweight at Morgan Stanley; PT $29

* Mondelez Rated New Overweight at Morgan Stanley; PT $69

* Scor Reinstated Buy at Goldman; PT 34.50 euros

* Simply Good Foods Reinstated Equal-Weight at Morgan Stanley

* WK Kellogg Rated New Underweight at Morgan Stanley; PT $18

>>> Call
* Novo Double-Downgraded at Intron Health on US Ozempic Softness